Ainos, Inc.
AIMDNasdaq
$1.65
↓ -2.9%Jul 17 close · end-of-day
Price
1Y↓ -40.9%
End-of-day closes; the latest point is the live 15-min-delayed price · split & dividend adjusted · chart by TradingView
Key statistics
Market Cap
$10.0M
Enterprise Value
$7.1M
P/E
—
P/S
549.5
P/B
1.7
EV/EBITDA
—
PEG
—
FCF Yield
-44.0%
Dividend Yield
—
Revenue (TTM)
$18,111.00
Net Income (TTM)
-$13.9M
Free Cash Flow (TTM)
-$4.4M
Gross Margin
79.1%
Operating Margin
-72393.5%
Net Margin
-76996.3%
ROE
-245.0%
ROIC
-363.4%
Debt / Equity
—
Net Cash
$2.8M
Return 1Y
-41.1%
Company profile
Ainos, Inc. engages in the developing medical technologies for point-of-care testing and safe and novel medical treatment for disease indications. The company offers COVID-19 antigen rapid test kit and Ainos' cloud-based test management App.
- CEO
- Chun-Hsien Tsai
- Sector
- Manufacturing
- Industry
- Pharmaceutical Products
- Employees
- 40
- Headquarters
- California
- Website
- ainos.com
Management & directors
- Tsai Chun-HsienCEO, PRESIDENT, CHAIRMAN
- Lee Hsin-Liang ChristopherCFO
Roles derived from SEC Form 4 filings.
Earnings
AIMD Q1 2026 Earnings
Period ends 2026-03-31
MetricActualYoY
Revenue$161.00↓ -99.8%
Diluted EPS-$0.41↓ -60.6%
Actuals from SEC filings; YoY vs the year-ago quarter. Analyst estimates & surprise require a data feed (coming soon).
Financial statements
| Line item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Revenue | $16,563.00 | $594,563.00 | $3.5M | $122,112.00 | $20,729.00 | $124,157.00 |
| Gross profit | $5,286.00 | $410,382.00 | $1.4M | -$253,733.00 | -$31,866.00 | $102,911.00 |
| Operating income | -$1.4M | -$3.9M | -$14.0M | -$13.2M | -$13.8M | -$14.0M |
| Net income | -$1.5M | -$3.9M | -$14.0M | -$13.8M | -$14.9M | -$14.8M |
| Diluted EPS | — | — | — | -$3.36 | -$7.82 | -$3.46 |
| Operating cash flow | -$499,551.00 | -$1.2M | -$3.0M | -$4.7M | -$5.8M | -$4.6M |
| Free cash flow | -$499,551.00 | -$1.4M | -$3.7M | -$4.8M | -$5.8M | -$4.6M |
| Gross margin | 31.9% | 69.0% | 39.9% | -207.8% | -153.7% | 82.9% |
| Operating margin | -8696.7% | -650.5% | -397.1% | -10815.0% | -66772.2% | -11268.3% |
| Net margin | -8758.2% | -654.0% | -398.0% | -11277.0% | -71702.3% | -11897.0% |
| Line item | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $0.00 | $0.00 | $0.00 | $106,207.00 | $4,663.00 | $2,167.00 | $11,120.00 | $161.00 |
| Gross profit | -$25,373.00 | -$547.00 | $79.00 | $87,974.00 | $3,726.00 | $1,690.00 | $9,521.00 | -$602.00 |
| Operating income | -$3.0M | -$3.0M | -$4.6M | -$3.2M | -$3.7M | -$2.8M | -$4.3M | -$2.3M |
| Net income | -$3.2M | -$3.7M | -$4.7M | -$3.3M | -$4.1M | -$2.9M | -$4.5M | -$2.5M |
| Diluted EPS | -$2.45 | -$1.64 | -$3.16 | -$1.04 | -$0.99 | -$0.64 | -$0.79 | -$0.41 |
| Operating cash flow | -$2.0M | -$1.5M | -$864,231.00 | -$1.2M | -$1.4M | -$1.2M | -$855,018.00 | -$983,421.00 |
| Free cash flow | -$2.0M | -$1.5M | -$865,139.00 | -$1.3M | -$1.4M | -$1.2M | -$856,547.00 | -$991,963.00 |
| Gross margin | — | — | — | 82.8% | 79.9% | 78.0% | 85.6% | -373.9% |
| Operating margin | — | — | — | -2978.0% | -80327.8% | -128481.4% | -38648.0% | -1418414.3% |
| Net margin | — | — | — | -3094.0% | -87604.3% | -135288.5% | -40182.5% | -1527826.1% |
Company news
Jun 29, 2026
Jun 17, 2026
Analyst estimates
Coming soonConsensus revenue & EPS estimates and price targets will appear here once a forward-estimates data feed is connected.
Insider transactions
BoughtSoldMonthly insider $ volume · trailing 12 months
| Date | Insider | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| 2026-06-05 | chiang yao-chung | Buy | 3,500 | $2.05 | $7,175.00 | filing |
| 2026-06-03 | chiang yao-chung | Buy | 2,000 | $2.13 | $4,260.00 | filing |
| 2026-05-28 | chiang yao-chung | Buy | 250 | $2.30 | $575.00 | filing |
| 2026-05-27 | chiang yao-chung | Buy | 2,000 | $2.00 | $4,000.00 | filing |
| 2026-05-26 | lee ting-chuan | Sale | 109,988 | $1.90 | $208,977.20 | filing |
| 2026-05-26 | Taiwan Carbon Nano Technology Corp | Sale | 41,000 | $2.36 | $96,760.00 | filing |
| 2026-05-26 | tsai chung-jung | Sale | 27,718 | $1.87 | $51,832.66 | filing |
| 2026-05-22 | lee ting-chuan | Sale | 9,302 | $1.57 | $14,604.14 | filing |
| 2026-05-22 | tsai chung-jung | Sale | 1,082 | $1.55 | $1,677.10 | filing |
| 2026-05-21 | lee ting-chuan | Sale | 9,000 | $1.56 | $14,040.00 | filing |
| 2026-05-19 | chiang yao-chung | Buy | 2,200 | $1.68 | $3,696.00 | filing |
| 2026-05-18 | chiang yao-chung | Buy | 500 | $1.65 | $825.00 | filing |
| 2026-05-05 | chiang yao-chung | Buy | 129 | $1.70 | $219.30 | filing |
| 2026-04-30 | chiang yao-chung | Buy | 200 | $1.68 | $336.00 | filing |
| 2026-04-29 | chiang yao-chung | Buy | 100 | $1.75 | $175.00 | filing |
| 2026-04-15 | lee ting-chuan | Award | 570,000 | $1.61 | $917,700.00 | filing |
| 2026-04-15 | tsai chung-jung | Award | 330,000 | $1.61 | $531,300.00 | filing |
| 2026-04-15 | tsai chun-hsien· CEO, PRESIDENT, CHAIRMAN | Award | 300,000 | $1.61 | $483,000.00 | filing |
| 2026-01-28 | Taiwan Carbon Nano Technology Corp | Sale | 46,000 | $2.17 | $99,806.20 | filing |
| 2026-01-09 | Taiwan Carbon Nano Technology Corp | Sale | 431 | $1.86 | $801.66 | filing |
| 2026-01-08 | Taiwan Carbon Nano Technology Corp | Sale | 850 | $1.80 | $1,534.08 | filing |
| 2025-11-25 | tsai chung-jung | Award | 80,000 | $2.10 | $168,000.00 | filing |
| 2025-11-25 | tsai chun-hsien· CEO, PRESIDENT, CHAIRMAN | Award | 80,000 | $2.10 | $168,000.00 | filing |
| 2025-11-25 | lee ting-chuan | Award | 80,000 | $2.10 | $168,000.00 | filing |
| 2025-11-25 | chang wen-han | Award | 50,000 | $2.10 | $105,000.00 | filing |
Showing the latest 25 transactions — full history in the linked SEC filings.
Fundamentals & filings from SEC EDGAR. Prices adjusted for splits & dividends. Not investment advice.